Abstract: An electronic control device 140 is mounted on an on-vehicle control system 10 that performs travel control of an automobile, and is communicatively connected to a plurality of control devices including a first control device (electronic control device 120) and a second control device (electronic control device 130). The electronic control device 140 includes an attack determination unit 145 that determines presence or absence of a security attack in each control device, and a redundant system execution determination unit 146 that determines whether to cause the second control device to execute a redundant function similar to or a part of the function performed by the first control device based on the result of determination by the attack determination unit 145.

Abstract: A crystal of ethane disulfonate of (S)-1-(4-(dimethylamino)piperidin-1-yl)-3-hydroxy-3-(1-methyl-1H-imidazol-2-yl)propan-1-one, having peaks at diffraction angles 2?)(° of 12.6±0.2, 16.0±0.2, 17.7±0.2, 18.5±0.2, and 21.3±0.2 in powder X-ray diffraction; and the crystal of ethane disulfonate of (S)-1-(4-(dimethylamino)piperi din-1-yl)-3-hydroxy-3-(1-methyl-1H-imidazol-2-yl)propan-1-one, having an endothermic peak at 173° C. to 177° C. in simultaneous thermogravimetric-differential thermal analysis.

Abstract: Provided are a friction stir welding apparatus and a friction stir welding method that achieve highly accurate and highly reliable joining while minimizing an effect of bending of a pressing force receiving portion (carrying table) as a result of a press by a joining tool unit. The friction stir welding apparatus joins joining target members by friction stir welding. The friction stir welding apparatus is characterized by including: an apparatus main body; a control device that controls an operation of the friction stir welding apparatus; a C-shaped frame connected to the apparatus main body via a first vertical movement drive mechanism unit; a holder unit connected to one end of the C-shaped frame via a second vertical movement drive mechanism unit; and a joining tool held by the holder unit.

Abstract: A friction stir welding apparatus and method maintains a depth of a welded part constant without varying a depth-direction position of a welding tool leading end part relative to welded members. A control device controls an operation of the friction stir welding apparatus, and a holder unit is connected to a swing mechanism unit via a revolving mechanism section, and a welding tool is held to the holder unit. The control device has a first welding mode in which friction stir welding is performed on the basis of a welding condition signal for deciding a welding condition of the welding tool, a swing control signal for controlling the swing mechanism unit, a first hold position decision signal, and a second welding mode in which friction stir welding is performed on the basis of the welding condition signal, the swing control signal, and a second hold position decision signal.

Abstract: A crystal of ethane disulfonate of (S)-1-(4-(dimethylamino)piperidin-1-yl)-3-hydroxy-3-(1-methyl-1H-imidazol-2-yl)propan-1-one, having peaks at diffraction angles 2? (°) of 12.6±0.2, 16.0±0.2, 17.7±0.2, 18.5±0.2, and 21.3±0.2 in powder X-ray diffraction; and the crystal of ethane disulfonate of (S)-1-(4-(dimethylamino)piperidin-1-yl)-3-hydroxy-3-(1-methyl-1H-imidazol-2-yl)propan-1-one, having an endothermic peak at 173° C. to 177° C. in simultaneous thermogravimetric-differential thermal analysis.

Abstract: Disclosed is a method for joining a metal member and a thermosetting resin member together with a thermoplastic resin interposed therebetween.

Abstract: A friction stir welding apparatus and method maintains a depth of a welded part constant without varying a depth-direction position of a welding tool leading end part relative to welded members. A control device controls an operation of the friction stir welding apparatus, and a holder unit is connected to a swing mechanism unit via a revolving mechanism section, and a welding tool is held to the holder unit. The control device has a first welding mode in which friction stir welding is performed on the basis of a welding condition signal for deciding a welding condition of the welding tool, a swing control signal for controlling the swing mechanism unit, a first hold position decision signal, and a second welding mode in which friction stir welding is performed on the basis of the welding condition signal, the swing control signal, and a second hold position decision signal.

Abstract: Crystals of a compound that exhibits an analgesic action against neuropathic pain and/or fibromyalgia syndrome are useful as pharmaceuticals. The crystals may be of (S)-1-(4-(dimethylamino)piperidin-1-yl)-3-hydroxy-3-(1-methyl-1H-imidazol-2-yl)propan-1-one or a pharmacologically acceptable salt thereof.

Abstract: Provided are a friction stir welding apparatus and a friction stir welding method that achieve highly accurate and highly reliable joining while minimizing an effect of bending of a pressing force receiving portion (carrying table) as a result of a press by a joining tool unit. The friction stir welding apparatus joins joining target members by friction stir welding. The friction stir welding apparatus is characterized by including: an apparatus main body; a control device that controls an operation of the friction stir welding apparatus; a C-shaped frame connected to the apparatus main body via a first vertical movement drive mechanism unit; a holder unit connected to one end of the C-shaped frame via a second vertical movement drive mechanism unit; and a joining tool held by the holder unit.

Abstract: Crystals of a compound that exhibits an analgesic action against neuropathic pain and/or fibromyalgia syndrome are useful as pharmaceuticals. The crystals may be of (S)-1-(4-(dimethylamino)piperidin-1-yl)-3-hydroxy-3-(1-methyl-1H-imidazol-2-yl)propan-1-one or a pharmacologically acceptable salt thereof.

Abstract: A cyclic amine derivative represented by a general formula (I) or a pharmacologically acceptable salt thereof: wherein n represents 1 or 3, R1 represents an alkyl group having 1 to 6 carbon atoms unsubstituted, substituted with a halogen atom or substituted with an alkyloxy group having 1 to 4 carbon atoms and R2 represents a hydrogen atom or a halogen atom.

Abstract: Disclosed is a method for joining a metal member and a thermosetting resin member together with a thermoplastic resin interposed therebetween.

Abstract: A compound exerts an analgesic effect against pain, in particular, neuropathic pain and/or fibromyalgia syndrome. A cyclic amine derivative represented by the following general formula, or a pharmacologically acceptable salt thereof: Methods using the compound including the cyclic amine derivative or a pharmacologically acceptable salt thereof to treat pain, neuropathic pain and fibromyalgia syndrome.

Abstract: A compound exerts a strong analgesic effect against pain, in particular, neuropathic pain and/or fibromyalgia syndrome. A cyclic amine derivative represented by general formula or a pharmacologically acceptable salt thereof: A method of treating neuropathic pain includes administering a therapeutically effective amount of the cyclic amine derivative to a mammal. A method of treating fibromyalgia syndrome includes administering a therapeutically effective amount of the cyclic amine derivative to a mammal.

Abstract: A compound exerts a strong analgesic effect against pain, in particular, neuropathic pain and/or fibromyalgia syndrome. A cyclic amine derivative represented by general formula or a pharmacologically acceptable salt thereof A method of treating neuropathic pain includes administering a therapeutically effective amount of the cyclic amine derivative to a mammal. A method of treating fibromyalgia syndrome includes administering a therapeutically effective amount of the cyclic amine derivative to a mammal.

Abstract: A cyclic amine derivative represented by a general formula (I) or a pharmacologically acceptable salt thereof: wherein n represents 1 or 3, R1 represents an alkyl group having 1 to 6 carbon atoms unsubstituted, substituted with a halogen atom or substituted with an alkyloxy group having 1 to 4 carbon atoms and R2 represents a hydrogen atom or a halogen atom.

Abstract: A compound exerts an analgesic effect against pain, in particular, neuropathic pain and/or fibromyalgia syndrome. A cyclic amine derivative represented by the following general formula, or a pharmacologically acceptable salt thereof: Methods using the compound including the cyclic amine derivative or a pharmacologically acceptable salt thereof to treat pain, neuropathic pain and fibromyalgia syndrome.

Abstract: A compound exerts a strong analgesic effect against pain, in particular, neuropathic pain and/or fibromyalgia syndrome. The cyclic amine derivative is represented by formula, a prodrug thereof or a pharmacologically acceptable salt thereof: wherein A represents a group represented by Formula (IIa), (IIb) or (IIc): wherein R3 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, R4 represents a hydrogen atom or an alkylcarbonyl group having 2 to 6 carbon atoms or an alkyl group having 1 to 6 carbon atoms and optionally substituted with an alkylcarbonylamino group having 2 to 6 carbon atoms and n represents 1 or 2, in which when R3 and R4 each independently represent an alkyl group having 1 to 6 carbon atoms, R1 represents an alkyl group having 1 to 6 carbon atoms and substituted with a hydroxyl group, an amino group or a carboxyl group.

Abstract: A compound exerts a strong analgesic effect against pain, in particular, neuropathic pain and/or fibromyalgia syndrome. The cyclic amine derivative is represented by formula, a prodrug thereof or a pharmacologically acceptable salt thereof: wherein A represents a group represented by Formula (IIa), (IIb) or (IIc): wherein R3 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, R4 represents a hydrogen atom or an alkylcarbonyl group having 2 to 6 carbon atoms or an alkyl group having 1 to 6 carbon atoms and optionally substituted with an alkylcarbonylamino group having 2 to 6 carbon atoms and n represents 1 or 2, in which when R3 and R4 each independently represent an alkyl group having 1 to 6 carbon atoms, R1 represents an alkyl group having 1 to 6 carbon atoms and substituted with a hydroxyl group, an amino group or a carboxyl group.

Abstract: A steering member comprises a beam member extending in a vehicle width direction, a steering bracket supporting a steering device, and side brackets fixed to hinge pillars. The beam member includes a weak portion provided between the steering bracket and the side brackets on a driver-seat side and configured to be weak against a load inputted in a vehicle longitudinal direction, and an extension portion provided to extend toward a vehicle outward side beyond the side bracket provided on a passenger-seat side and configured to prevent the steering member receiving the input load from sliding toward the passenger-seat side by contacting the hinge pillar. Accordingly, the steering device can be prevented from moving inward in a vehicle frontal collision, thereby restraining a passenger with an airbag properly.